Advanced Pancreatic Cancer Model for Developing Personalized Therapies (IMAGE)
Caption
Scientists from the Terasaki Institute for Biomedical Innovation have recently designed an advanced pancreatic tumor model which more accurately depicts pancreatic ductal adenocarcinoma tumor progression. Using this model to elucidate the interactive factors that influence this progression may lead to the development of personalized modeling and drug testing applications.
Credit
Terasaki Institute for Biomedical Innovation
Usage Restrictions
Request permission from Terasaki Institute for Biomedical Innovation
License
Original content